These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20442570)

  • 1. Cytokine networks in multiple sclerosis: lost in translation.
    Codarri L; Fontana A; Becher B
    Curr Opin Neurol; 2010 Jun; 23(3):205-11. PubMed ID: 20442570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine signaling in multiple sclerosis: Lost in translation.
    Göbel K; Ruck T; Meuth SG
    Mult Scler; 2018 Apr; 24(4):432-439. PubMed ID: 29512406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drug therapies for multiple sclerosis.
    Mangas A; Coveñas R; Geffard M
    Curr Opin Neurol; 2010 Jun; 23(3):287-92. PubMed ID: 20414110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
    Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
    Durelli L; Conti L; Clerico M; Boselli D; Contessa G; Ripellino P; Ferrero B; Eid P; Novelli F
    Ann Neurol; 2009 May; 65(5):499-509. PubMed ID: 19475668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA; Millward JM; Owens T
    J Neuroimmunol; 2007 Nov; 191(1-2):79-85. PubMed ID: 17920696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into adaptive immunity in chronic neuroinflammation.
    Siffrin V; Brandt AU; Herz J; Zipp F
    Adv Immunol; 2007; 96():1-40. PubMed ID: 17981203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ.
    Aharoni R; Kayhan B; Eilam R; Sela M; Arnon R
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14157-62. PubMed ID: 14614135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis: a complicated picture of autoimmunity.
    McFarland HF; Martin R
    Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
    Reske D; Thomas AV; Petereit HF; Fink GR; Schroeter M
    Neuroimmunomodulation; 2009; 16(6):385-91. PubMed ID: 19609087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
    Batoulis H; Addicks K; Kuerten S
    Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytes stimulate interleukin-17 and interferon-gamma production in vitro.
    Miljkovic D; Momcilovic M; Stojanovic I; Stosic-Grujicic S; Ramic Z; Mostarica-Stojkovic M
    J Neurosci Res; 2007 Dec; 85(16):3598-606. PubMed ID: 17969033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
    Bar-Or A; Fawaz L; Fan B; Darlington PJ; Rieger A; Ghorayeb C; Calabresi PA; Waubant E; Hauser SL; Zhang J; Smith CH
    Ann Neurol; 2010 Apr; 67(4):452-61. PubMed ID: 20437580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
    Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
    J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis and therapy of multiple sclerosis. The role of cytokines].
    Weber F; Rieckmann P
    Nervenarzt; 1995 Feb; 66(2):150-5. PubMed ID: 7715757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of progressive demyelinating autoimmune encephalomyelitis in common marmoset monkeys using MOG34-56 peptide in incomplete freund adjuvant.
    Jagessar SA; Kap YS; Heijmans N; van Driel N; van Straalen L; Bajramovic JJ; Brok HP; Blezer EL; Bauer J; Laman JD; 't Hart BA
    J Neuropathol Exp Neurol; 2010 Apr; 69(4):372-85. PubMed ID: 20448482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell transplantation in multiple sclerosis.
    Uccelli A; Mancardi G
    Curr Opin Neurol; 2010 Jun; 23(3):218-25. PubMed ID: 20375893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.